Senate Hearing on Drug Supply Chain and Bipartisan Support for Domestic Manufacturing
The Senate Aging Committee recently held a hearing focusing on the drug supply chain, highlighting bipartisan support for policies promoting domestic drug manufacturing. Chairperson Scott (R-FL) advocated for the CLEAR LABELS Act (S. 3788), which mandates prescription drug labels to specify the original manufacturers of generic drugs and the sources of active pharmaceutical ingredients, including countries of origin. Testimonies underscored the critical role of regulatory measures in facilitating biotechnology innovation, enhancing U.S.-based drug production.
The CMS Innovation Center has invited applications for the BALANCE model, a voluntary initiative introduced in December 2025 aimed at improving the availability of GLP-1 medications and promoting healthy lifestyles. This initiative provides a framework for state Medicaid agencies and Medicare Part D plans to enhance healthcare delivery. Moreover, the Centers for Medicare & Medicaid Services (CMS) updated its organ procurement guidance, emphasizing the responsibilities of organ procurement organizations (OPOs) and donor hospitals, particularly in terms of ethical donor interactions and compliance requirements.
In legal developments, labor organizations have filed lawsuits against the administration over CDC grant funding withdrawals, arguing that the cessation of $600 million disproportionately affected states with Democratic leadership. The American Federation of State, County, and Municipal Employees accused the administration of using artificial intelligence to retroactively justify these actions. This prompted affected states like California, Colorado, Illinois, and Minnesota to seek judicial intervention, securing a temporary restraining order that halted the funding clawbacks for 14 days. Meanwhile, Congress is set to reconvene next week with important hearings, while the CMS gears up for its 2026 Quality Conference, as the industry awaits the presidential budget proposal.